Alembic Pharmaceuticals informs about press release

23 Nov 2021 Evaluate

Alembic Pharmaceuticals has informed that it enclosed a press release regarding receipt of US Food & Drug Administration (USFDA) Tentative Approval for Dabigatran Etexilate Capsules, 150 mg.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

839.05 -4.10 (-0.49%)
30-Dec-2025 13:04 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1708.25
Dr. Reddys Lab 1260.30
Cipla 1479.95
Zydus Lifesciences 899.15
Lupin 2069.90
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×